on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Interests in Mural Oncology
The Vanguard Group, Inc. has disclosed its interests in Mural Oncology plc under Form 8.3, as required by the Irish Takeover Panel. The disclosure indicates that Vanguard holds relevant securities, amounting to 1.67% of $0.01 ordinary shares, equating to 288,907 shares.
As of October 29, 2025, Vanguard is not party to any other interests or short positions beyond those reported. The document indicates that there were no significant derivative transactions or any other dealing arrangements in connection with Mural Oncology.
No agreements, formal or informal, inducing dealing or refraining from dealing in the securities were reported. Additionally, there are no supplemental attachments or further undertakings associated with this disclosure.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news